期刊文献+

柱前衍生高效液相色谱法测定人血浆中尿囊素浓度 被引量:3

Pre-column derivatized HPLC determination of allantoin in plasma
下载PDF
导出
摘要 目的:建立血浆中尿囊素的浓度测定方法。方法:采用柱前衍生反相高效液相色谱法,尿囊素与2,4-二硝基苯肼(DNPH)反应生成2,4-二硝基苯腙,色谱柱为Phenomenex Luna C18色谱柱(150mm×4.6mm,5μm),柱温为室温。流动相A为0.2%冰醋酸(用三乙胺调pH至5.0),流动相B为乙腈。梯度洗脱程序:A与B的体积比变化为0~3min 85:15~65:35(曲线系数为7),3-5min 65:35~15:85(曲线系数为7),5~9min 15:85~15:85(曲线系数为6),9~10min 15:85~85:15(曲线系数为6),10~15min 85:15(曲线系数为6)。PAD检测波长:340nm,流速1.0mL·min-1。内标为加替沙星。结果:在此色谱条件下,尿囊素衍生物与血浆中其他成分的分离完全,线性检测范围为2.5-40mg·L-1,最低检测浓度为2.5mg·L-1,相对回收率在99.35%~103.14%之间,日内及日间精密度RSD小于2.1%。结论:柱前衍生反相高效液相色谱法稳定、灵敏、可靠,可用于人体血浆中尿囊素浓度的测定。 Objective:To establish a method for determination of allantoin in plasma. Methods: Allantoin sample was derivatized by reaction with 2,4-dinitrophenyhydrazine and then separated in a Phenomenex(?) Luna C18 column of room temperature by programmed gradient elution procedure using mobile phase A (0.2% acetic acid pH 5.0) and mobile phase B (acetonitrile) with a flow rate of 1.0 mL·min-1 and detected with a UV detector at 340nm. Gatifloxacin was adopted as the internal standard . Results: Under this chromatographic conditions,allantoin could be completely separated from oth-er components in the sample with a linear range of 2.5-40mg·L-1,a detection limit of 2.5mg·L-1, a relative recovery range of 99.35 %-103.14 % , and an intra- and inter-day RSD of < 2.1% . Conclu-sion:A simple,accurate,and reproducible method is established for determination of allantoin in plasma.
出处 《中国新药杂志》 CAS CSCD 北大核心 2004年第5期435-438,共4页 Chinese Journal of New Drugs
关键词 尿囊素 高效液相色谱 柱前衍生 血药浓度 allantoin HPLC pre-column derivatization concentration
  • 相关文献

参考文献6

  • 1MARTINDALE[M].13 Edition.USA:The royal pharmaceutical society,1996.1078.
  • 2Czauderna M,Kowalczyk J.Simulaneous measurement of allantoin,uric acid,xanthine and hypoxanthine in blood by high-performance liquid chromatography[J].J Chromatogr B,1997,704(1-2):89-98.
  • 3Chen XB,Kyle DJ,Orskov ER.Measurement of allantoin in urine and plasma by high-performance liquid chromatography with pre-column derivatization[J].J Chromatogr,1993,617:241-247.
  • 4Berthemy A,Newton J,Wu D.Quantitative determination of an extremely polar compound allantoin in human urine by LC-MS/MS based on the separation on a polymeric amino column[J].J Pharm Biomed Anal,1999,19(3-4)∶429-434.
  • 5Terzuoli L,Poercelli B,Seeracci C.Comparative determination of purine compounds in carotid plaque by capillary zone electrophoresis and high-performance liquid chromatography[J].J Chromatogr B,1999,728(2)∶185-192.
  • 6Yamamoto R,Seki M,Ouchi K,et al.A rapid determination of allantoin by high-performance liquid chromatography using tris(hydroxymethyl) aminomethane-HCL buffer as a mobile phase[J].Yakugaku Zasshi,1998,118(8)∶310-316.

同被引文献21

  • 1周心如,曹京宜.山药中尿囊素的高效液相色谱分析方法研究[J].色谱,1996,14(2):129-131. 被引量:16
  • 2周本宏,张帆,罗顺德,蔡鸿生.痤疮霜中尿囊素的薄层色谱测定法[J].华西药学杂志,1996,11(3):175-176. 被引量:5
  • 3孙汝东.尿囊素的pH滴定法[J].中国药学杂志,1997,32(3):163-164. 被引量:7
  • 4[6]Czauderna M,Kowalczyk J.Simulaneous measurement of allantoin,uric acid,xanthine and hypoxanthiRe in blood by highperformance liquid chromatography[J].J Chromatogr B,1997,704(1):89-98.
  • 5[7]Chen XB,Kyh DJ,Orskov ER.Measurement of allantoin in urine and plasma by highy-perfomance liquid chromatography with precolumn defivatiation[J].J Chromatogr,1993,617(3):241-247.
  • 6The United Stateo Pharmacopeial Convention. US Pharma-copeia[ M]. 29 ed. 2005 :74.
  • 7李建其,吕娜,金华,等.1-丁基-2-羟基芳烷哌嗪衍生物及作为抗抑郁剂应用,中国:101712658 [P].2010-05-26.
  • 8ZHENG YY,XIE P,XING LX,et al. Development and practical synthesis of a triple reuptake inhibitor, (1R,2S) -SIPI 5357 [ J ]. Process Res Dev,2012,16 : 1921 - 1926.
  • 9European Medicines Agency. Guideline on the Limits of genotox- ic impurities[ S ]. CPMP/SWP/5199/02, EMEA/CHMP/QWP/ 251344/2006.
  • 10史继峰.EMEA《遗传毒性杂质限度指导原则》介绍[EB/OL].[2013-08-01].http://www.cde.org.en/dzkw.do?method=largePage&id=2054.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部